XTalks

NOVEMBER 6, 2020

The Burnaby, BC-based company developed the oral DNA-based vaccine using its proprietary bacTRL Gene Therapy Platform, which uses genetically modified bifidobacteria as carriers of genetic vaccine elements on a DNA plasmid. Related: Red Meat Allergy Test Gets FDA Clearance. “We

Clinical Trials 75

Clinical Trials Clinical Trials Vaccination Vaccine 75

The Pharma Data

JUNE 14, 2023

Pseudomonas aeruginosa, a common environmental bacterium, can colonize different body parts, such as the lungs, leading to persistent, chronic infections that can last a lifetime – a common occurrence in people with cystic fibrosis. .” They named the small RNA SicX (sRNA inducer of chronic infection X).

RNA 40

RNA Regulation Scientist Bacteria 40

Drug Discovery World

NOVEMBER 17, 2022

The rapidly growing area of synthetic biology – including molecular biology, biotechnology, biophysics, and genetic engineering – is having a marked impact on the drug discovery landscape. Bacteria are complicated, and just because we can sequence a gene doesn’t mean we know how the bacteria would turn it on to produce proteins,” Brady added.

Bacteria 52

Bacteria Engineer Gene Genetics 52

XTalks

DECEMBER 24, 2020

However, for virologists like Lori Frappier, PhD, professor in the department of molecular genetics at the University of Toronto, the outbreak of SARS-CoV-2 was less of a surprise and more of an inevitability. Most antibody drugs and vaccines have been developed to target parts of the spike protein.

Life Science 111

Life Science Vaccination Vaccine Gene 111

XTalks

NOVEMBER 10, 2020

The genetic sequence of a virus is generated using recombinant technology and the resulting virus-like particles (VLP) mimic the shape and dimensions of a virus, which the body recognizes as being foreign and elicits an immune response against. However, Medicago’s plant-based design uses living plants as the viral host instead of an animal.

Vaccination 52

Vaccination Vaccine Trials Immune Response 52